10x Genomics, Inc. - Common Stock (NQ:TXG)

76.10 -4.56 (-5.65%)

Delayed Quote Updated: 4:00 PM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about 10x Genomics, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stocks That Hit 52-Week Lows On Thursday ↗

January 06, 2022

On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this...

Via Benzinga

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

Recap: 10x Genomics Q1 Earnings ↗

May 13, 2021

Shares of 10x Genomics (NASDAQ:TXG) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share rose 186.96% over the past year to $0.66...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

January 05, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...

Via Benzinga

FedEx Options Trade & Stock Analysis ↗

December 19, 2021

This week we discuss last week's performance of our trades in the NUGT ETF. We also review our trade of FedEx after recent earnings.

Via Talk Markets

10x Genomics Stock: Bull vs. Bear ↗

November 24, 2021

After a hot start, the stock has recently lagged the market. Is now a good time to buy?

Via The Motley Fool

Topics Initial Public Offering

Notable 10X Genomics Insider Trades $2.8M In Company Stock ↗

November 17, 2021

Bradford Crutchfield, Insider at 10X Genomics (NASDAQ:TXG), made a large buy and sell of company shares on November 12, according to a new SEC filing. What Happened: A Form 4...

Via Benzinga

Topics Regulatory Compliance

Better Buy: 10x Genomics vs. DermTech ↗

November 11, 2021

Both companies offer disruptive new solutions in their niches of the healthcare space.

Via The Motley Fool

Chief Executive Officer Of 10X Genomics Trades $2.5M In Company Stock ↗

November 05, 2021

Serge Saxonov, Chief Executive Officer at 10X Genomics (NASDAQ:TXG), made a large buy and sell of company shares on November 2, according to a new SEC filing. What Happened: A...

Via Benzinga

Topics Regulatory Compliance

10x Genomics Clocks 74% Jump In Q3 Revenues; Raises Top End Of Sales Guidance ↗

November 04, 2021

10x Genomics Inc (NASDAQ: TXG) reported Q3 sales of $125.3 million, beating the consensus of $122.62 million. Sales increased 74% Y/Y, primarily due to increased...

Via Benzinga

10X Genomics Inc (TXG) Q3 2021 Earnings Call Transcript ↗

November 03, 2021

TXG earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering ↗

November 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...

Via Benzinga

Topics Retirement

Earnings Scheduled For November 3, 2021 ↗

November 03, 2021

Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion....

Via Benzinga

Earnings Preview: 10x Genomics ↗

November 02, 2021

10x Genomics (NASDAQ:TXG) is set to give its latest quarterly earnings report on Wednesday, 2021-11-03. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Notable 10X Genomics Insider Trades $2.7M In Company Stock ↗

October 15, 2021

Bradford Crutchfield, Chief Commercial Officer at 10X Genomics (NASDAQ:TXG), made a large buy and sell of company shares on October 12, according to a new SEC filing. What...

Via Benzinga

Topics Regulatory Compliance

3 COVID Stocks That Can Turn $1,000 Into $10,000 ↗

October 12, 2021

Our trio of contributors offer three COVID-19 stocks that will zoom higher, even as we emerge from the pandemic.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2021 ↗

September 16, 2021

Upgrades For Signet Jewelers Ltd (NYSE:

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Why 10x Genomics Shares Are Trading Lower Today ↗

September 14, 2021

10x Genomics (NASDAQ:TXG) shares are trading lower after B of A Securities downgraded the stock from Buy to Neutral and announced a $180 price target. 10x Genomics' stock...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2021 ↗

September 14, 2021

Upgrades Northcoast Research upgraded the previous rating for Casey's General Stores Inc ...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 04, 2021

Gainers Scopus BioPharma (NASDAQ:SCPS) s...

Via Benzinga

Earnings Scheduled For August 5, 2021 ↗

August 05, 2021

Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million. •...

Via Benzinga

Earnings Scheduled For August 4, 2021 ↗

August 04, 2021

Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to...

Via Benzinga

The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs ↗

June 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs ↗

June 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Stocks That Hit 52-Week Highs On Tuesday ↗

June 29, 2021

Tuesday's morning session saw 105 companies set new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was...

Via Benzinga

Here's Why 10x Genomics Can't Satisfy Short-Term Investors ↗

May 29, 2021

Long-term investors should keep perspective.

Via The Motley Fool

10x Genomics Stock Shows Rising Price Performance With Jump To 83 RS Rating ↗

May 28, 2021

On Friday, biotech 10x Genomics stock received an upgrade to its Relative Strength (RS) Rating to 83, from 80 on Thursday.

Via Investor's Business Daily

Down More Than 20%, Is This Cathie Wood Biotech A Buy? ↗

May 20, 2021

10x Genomics stock has fallen, despite announcing strong first-quarter numbers.

Via The Motley Fool

These 7 Medical Stocks Are Breaking Down — The Sell Rule You Should Know ↗

May 13, 2021

Former high-flyers Dexcom and Tandem Diabetes are among seven health care stocks breaking down right now, according to MarketSmith.com.

Via Investor's Business Daily

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.